Table 1 Clinical characteristics of diabetic and non-diabetic patients with KPLA
Non-DM (n = 120) | DM (n = 110) | p | |
|---|---|---|---|
Age in years | 64.1 ± 16.3 | 63.5 ± 14.6 | 0.779 |
Male | 69 (57.5) | 80 (72.7) | 0.016 |
Charlson score | 1.1 ± 1.8 | 2.4 ± 1.9 | <0.001 |
Underlying disease | |||
Malignancy | 11 (9.2) | 10 (9.1) | 0.984 |
Alcoholism | 4 (3.3) | 8 (7.3) | 0.180 |
Chronic kidney disease | 4 (3.3) | 8 (7.3) | 0.180 |
Liver cirrhosis | 5 (4.2) | 1 (0.9) | 0.215 |
Congestive heart failure | 8 (6.7) | 5 (4.5) | 0.487 |
Chronic lung disease | 5 (4.2) | 5 (4.5) | 1.000 |
Cerebrovascular accident | 11 (9.2) | 8 (7.3) | 0.602 |
APACHE II score | 12.3 ± 6.9 | 14.5 ± 7.4 | 0.018 |
HbA1c | 5.6 ± 1.2 | 9.2 ± 2.6 | <0.001 |
Capsular type K1 and K2 | 94 (81.7)a | 70 (70.7)b | 0.057 |
Wild-type antibiotic susceptibility | 113 (94.2) | 103 (93.6) | 0.867 |
Origin | 0.749 | ||
Cryptogenic | 103 (85.8) | 96 (87.3) | |
Biliary tract origin | 17 (14.2) | 14 (12.7) | |
Abscess location | 0.408 | ||
Right lobe | 77 (64.2) | 79 (71.8) | |
Left lobe | 21 (17.5) | 17 (15.5) | |
Both lobes | 22 (18.3) | 14 (12.7) | |
Abscess size | 0.419 | ||
<5 cm | 51 (42.5) | 41 (37.3) | |
≥5 cm | 69 (57.5) | 69 (62.7) | |
Gas-forming abscess | 2 (1.7) | 18 (16.4) | <0.001 |
Multiple abscesses | 18 (15.0) | 15 (13.6) | 0.768 |
Metastatic infection | 6 (5.0) | 12 (10.9) | 0.096 |
Outcomes | |||
ICU admission | 23 (19.2) | 28 (25.5) | 0.252 |
Hospital days | 26.9 ± 16.5 | 32.3 ± 38.5 | 0.178 |
Mortality | 4 (3.4) | 4 (3.6) | 0.910 |